Beijing
China
Peking University - Department of Endocrinology and Metabolism
biological disease-modifying antirheumatic drugs, fractures, autoimmune diseases, meta-analysis
ATTR, cardiovascular prognosis, dapagliflozin, heart failure, transthyretin cardiac amyloidosis